Abstract
In the SELENIB trial, selenium and vitamin E were compared with placebo as chemoprevention for non-muscle-invasive bladder cancer (NMIBC). No difference versus placebo was observed in recurrence-free interval (RFI) with selenium, but vitamin E was associated with worse RFI. Selenium and vitamin E cannot be recommended in chemoprevention for NMIBC. Furthermore, patients with NMIBC taking supplemental vitamin E should be made aware of its potential association with worse RFI.
Original language | English (US) |
---|---|
Pages (from-to) | 458-459 |
Number of pages | 2 |
Journal | Nature Reviews Urology |
Volume | 21 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2024 |
ASJC Scopus subject areas
- Urology